Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase
- PMID: 6362777
- DOI: 10.1016/0006-8993(83)90046-x
Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase
Abstract
Immunohistochemically identified cholinergic neurons in the basal nucleus of Meynert in a brain with SDAT have been compared with those in two age- and sex-matched normal brains. The numbers of such cells at carefully matched levels are not significantly lower, but the cells in SDAT are substantially smaller than in the normal basal nucleus. The persistence of shrunken cholinergic neurons in the basal nucleus in the diseased brain is similar to that seen in an experimental study of retrograde cellular degeneration in the nucleus following damage of the cortex.
Similar articles
-
Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease.Adv Neurol. 1987;45:393-7. Adv Neurol. 1987. PMID: 2881448 No abstract available.
-
Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia.J Comp Neurol. 1988 Jul 22;273(4):543-57. doi: 10.1002/cne.902730409. J Comp Neurol. 1988. PMID: 2463283
-
Neuronal pathology in the nucleus basalis and associated cell groups in senile dementia of the Alzheimer's type: possible role in cell loss.Neurology. 1985 Aug;35(8):1089-95. doi: 10.1212/wnl.35.8.1089. Neurology. 1985. PMID: 4022341
-
The nucleus basalis of Meynert in neurological dementing disease: a review.Int J Neurosci. 1987 Nov;37(1-2):31-48. doi: 10.3109/00207458708991799. Int J Neurosci. 1987. PMID: 2960633 Review.
-
The cholinergic deficit in Alzheimer's disease.J Clin Psychiatry. 1998;59 Suppl 13:19-22. J Clin Psychiatry. 1998. PMID: 9771826 Review.
Cited by
-
Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer's Disease: Nexus of Cholinergic and Nerve Growth Factor Dysfunction.Curr Alzheimer Res. 2021;18(13):1010-1022. doi: 10.2174/1567205018666211215150547. Curr Alzheimer Res. 2021. PMID: 34911424 Free PMC article. Review.
-
Locus coeruleus damage and noradrenaline reductions in multiple sclerosis and experimental autoimmune encephalomyelitis.Brain. 2011 Mar;134(Pt 3):665-77. doi: 10.1093/brain/awq362. Epub 2011 Feb 4. Brain. 2011. PMID: 21297130 Free PMC article.
-
Deep brain stimulation of the nucleus basalis of Meynert in Alzheimer's dementia.Mol Psychiatry. 2015 Mar;20(3):353-60. doi: 10.1038/mp.2014.32. Epub 2014 May 6. Mol Psychiatry. 2015. PMID: 24798585
-
Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme.Psychopharmacology (Berl). 2008 May;198(1):1-27. doi: 10.1007/s00213-008-1092-0. Epub 2008 Feb 19. Psychopharmacology (Berl). 2008. PMID: 18392810 Review.
-
Rita Levi-Montalcini, NGF Metabolism in Health and in the Alzheimer's Pathology.Adv Exp Med Biol. 2021;1331:119-144. doi: 10.1007/978-3-030-74046-7_9. Adv Exp Med Biol. 2021. PMID: 34453296
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical